高级检索
当前位置: 首页 > 详情页

Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients

| 认领 | |

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究参与人:
研究单位: [1]Chipscreen Biosciences, Ltd. [2]Tongji Hospital Affiliated to Tongji Medical College of HUST Wuhan, Hubei, China, 430030 [3]Tongji Hospital Affiliated to Tongji University Shanghai, Shanghai, China, 200065 [4]Shanghai First People's Hospital Shanghai, Shanghai, China, 200080 [5]Shanghai 6th People's Hospital Shanghai, Shanghai, China, 200235 [6]Shanghai 5th People's Hospital Shanghai, Shanghai, China, 200240 [7]The Central Hospital of Minhang District of Shanghai Shanghai, Shanghai, China, 201199 [8]The First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shanxi, China, 710061 [9]Sichuan Provincial People's Hospital Chengdu, Sichuan, China, 610072 [10]Shanghai Changzheng Hospital Shanghai, Shanghai, China, 200003 [11]The Qingpu Branch of Zhongshan Hospital Affiliate to Fudan University Shanghai, Shanghai, China, 200043 [12]The First Affiliated Hospital of Dalian Medical University Dalian, Liaoning, China, 116044 [13]The First Hospital of China Medical University Shenyang, Liaoning, China, 110001 [14]Huai'an First People's Hospital Huai'an, Jiangsu, China, 223300 [15]Gulou Hospital Affiliated to Nanjing Medical University Nanjing, Jiangsu, China, 210008 [16]The Second Hospital Affiliated to Nanjing Medical University Nanjing, Jiangsu, China, 210009 [17]Nanjing First Hospital Nanjing, Jiangsu, China, 210029 [18]The Affiliated Hospital of Jiangsu University Zhenjiang, Jiangsu, China, 212013 [19]The First Hospital of Jilin University Changchun, Jilin, China, 100031 [20]The First Hospital Affiliated to Nanhua University Hengyang, Hunan, China, 421001 [21]The First People's Hospital of Yueyang Yueyang, Hunan, China, 414000 [22]The Affiliated Hospital of Inner Mongolia Hohhot, Inner Mongolia, China, 010050 [23]Beijing University Shenzhen Hospital Shenzhen, Guangdong, China, 518036

关键词: Chiglitazar Sitagliptin diabetes type 2 diabetes

研究目的:
The purpose of this study is to evaluate the efficacy and safety of Chiglitazar, compare with Sitagliptin.

资源点击量:432 今日访问量:0 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)